NORTH AMERICA COUGH SYRUP MARKET 2022-2028

 

 

TABLE OF CONTENTS

1.     NORTH AMERICA COUGH SYRUP MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE COUGH SYRUP MARKET

2.2. KEY INSIGHTS

2.2.1.    INCREASING DEMAND FOR HERBAL COUGH SYRUPS

2.2.2.    COMPANIES PROVIDE SUGAR-FREE COUGH SYRUPS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    INCREASING CHRONIC RESPIRATORY DISEASES

2.7.2.    RISE IN OLDER POPULATION

2.8. MARKET CHALLENGES

2.8.1.    OVERDOSE RISK

2.8.2.    STRICT GOVERNMENT REGULATIONS AND RESTRICTIONS

2.9. MARKET OPPORTUNITIES

2.9.1.    INCREASE IN CHILD-FRIENDLY COUGH SYRUP FLAVORS

2.9.2.    GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9.3.    SPECIAL PEDIATRIC COUGH SYRUPS

3.     NORTH AMERICA COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS/ANTITUSSIVES

3.2. COMBINATION MEDICATIONS

3.3. EXPECTORANTS

4.     NORTH AMERICA COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP

4.1. ADULT

4.2. PEDIATRIC

5.     NORTH AMERICA COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACY

5.2. HOSPITAL PHARMACY

5.3. ONLINE PHARMACY

6.     NORTH AMERICA COUGH SYRUP MARKET – COUNTRY OUTLOOK

6.1. UNITED STATES

6.2. CANADA

7.     COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ACELLA PHARMACEUTICALS LLC

7.3. ASTRAZENECA PLC

7.4. CIPLA LIMITED

7.5. DABUR INDIA LTD

7.6. GLAXOSMITHKLINE

7.7. GLENMARK PHARMACEUTICALS LIMITED

7.8. JOHNSON AND JOHNSON

7.9. MERCK KGAA

7.10.               NOVARTIS INTERNATIONAL AG

7.11.               PFIZER INC

7.12.               PROCTOR AND GAMBLE CO

7.13.               RECKITT BENCKISER GROUP PLC

7.14.               SANOFI SA

7.15.               THE HIMALAYA DRUG COMPANY

8.     RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

 

LIST OF TABLES

TABLE 1: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020

TABLE 4: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2022-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)

TABLE 7: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 3: NORTH AMERICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN $ MILLION)

FIGURE 4: NORTH AMERICA COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 5: NORTH AMERICA COUGH SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)

FIGURE 6: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)

FIGURE 7: NORTH AMERICA COUGH SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA COUGH SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2028 (IN %)

FIGURE 10: NORTH AMERICA COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 14: UNITED STATES COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 15: CANADA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

According to Triton Market Research, the cough syrup market in North America is assessed to attain a compound annual growth rate of 2.89% in revenue over the forecasting years from 2022 to 2028. The United States and Canada form the market in the studied region.

In Canada, the elderly population is significantly growing. As per sources, seniors account for around 17.5% of the total population. More than 3 million people suffer from respiratory conditions such as asthma, chronic obstructive pulmonary disease, lung cancer, and TB. The risk of COPD is increasing rapidly in the country, with a significant amount of the population affected each year. This rise in respiratory conditions is anticipated to drive the demand for cough syrup, thereby driving the cough syrup market.

In the United States, around 16.5% of the population is 65 years or older. This has increased the risk of respiratory conditions in the geriatric population. Moreover, chronic cough has become highly prevalent among adults. As per sources, the country witnessed a large number of cold cases each year. Besides this, air pollution in major cities is another factor that has increased COPD and other respiratory conditions across the nation. Therefore, the rise in the elderly population and increased respiratory diseases are fueling the cough syrup market’s growth.

 

Get more Insights into the North America Cough Syrup Market:

 

https://www.tritonmarketresearch.com/reports/north-america-cough-syrup-market

 

 

COMPETITIVE OUTLOOK

The eminent companies thriving in the cough syrup market include Cipla Limited, Proctor and Gamble Co, Acella Pharmaceuticals LLC, and Dabur India Ltd.

 

 

SEGMENTATION

1.     ABBOTT LABORATORIES

2.     ACELLA PHARMACEUTICALS LLC

3.     ASTRAZENECA PLC

4.     CIPLA LIMITED

5.     DABUR INDIA LTD

6.     GLAXOSMITHKLINE

7.     GLENMARK PHARMACEUTICALS LIMITED

8.     JOHNSON AND JOHNSON

9.     MERCK KGAA

10. NOVARTIS INTERNATIONAL AG

11. PFIZER INC

12. PROCTOR AND GAMBLE CO

13. RECKITT BENCKISER GROUP PLC

14. SANOFI SA

15. THE HIMALAYA DRUG COMPANY